Sequenom Provides Further Details on T21 Test Timeline | GenomeWeb

By Edward Winnick

NEW YORK (GenomeWeb News) – A Sequenom official yesterday provided an update on the firm's timeline for commercialization of its highly anticipated trisomy 21 non-invasive, pre-natal test.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Cell this week: phosphoproteomic patterns in prostate cancer, effect of gene expression on fitness in yeast, and more.

Scripps Research Institute investigators peer back at the RNA world.

Being born premature shouldn't mean infants with high blood sugar levels don't undergo genetic testing for neonatal diabetes, a study in Pediatrics says.

In PNAS this week: chromosome instability in S. cerevisiae, structural differences and sequence divergence in rice, and more.